Stay updated with breaking news from Anthony Deboer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lonza Group AG / Key word(s): Acquisition/Mergers & Acquisitions Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering 01.06.2023 / 07:00 CET/CEST Lonza to acquire
The expanded antibody-drug conjugate (ADC) collaboration includes up to $2.2bn in total potential payments plus tiered royalties on net sales.
/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...
/PRNewswire/ -- The "ADC Contract Manufacturing Market by Phase of Development, Scale of Operation, Type of Component Manufacturing, Target Indications, Type...
AMSTERDAM, Dec. 13, 2022 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug